Gilead Sciences Inc (NASDAQ:GILD)

69.20
Delayed Data
As of Nov 16
 -0.58 / -0.83%
Today’s Change
64.27
Today|||52-Week Range
89.54
-3.41%
Year-to-Date

Today’s Trading

Previous close69.78
Today’s open69.45
Day’s range68.93 - 69.70
Volume8,059,111
Average volume (3 months)6,551,905
Market cap$90.3B
Data as of 3:59pm ET, 11/16/2018

Growth & Valuation

Earnings growth (last year)-64.88%
Earnings growth (this year)-21.96%
Earnings growth (next 5 years)-2.77%
Revenue growth (last year)-13.79%
P/E ratio56.7
Price/Sales3.62
Price/Book4.46

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+2.33+0.72%
AMGNAmgen+1.73+0.90%
ILMNIllumina Inc+0.42+0.13%
TLRYTilray Inc+3.21+2.99%
Data as of 4:00pm ET, 11/16/2018

Financials

Next reporting dateFebruary 5, 2019
EPS forecast (this quarter)$1.71
Annual revenue (last year)$26.1B
Annual profit (last year)$4.6B
Net profit margin17.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
CFO, Principal Accounting Officer &
Executive VP
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts